Claris Lifesciences IPO Subscription Rate 9% only
Claris Lifesciences IPO Subscription Rate 9% only
Claris Lifesciences, a pharmaceutical company offered Initial public offer IPO about Rs. 300 Cr for subscription. Now the company has subscribed just 0.09 times or nine percent upto yesterday as data on NSE & BSE. The price band of Rs. 300 crore issue ends on Noveber 26 2010 and the price band is about Rs. 278-293 per share.
The company Claris Lifesciences offers 128 products targeted across multiple markets and therapeutic areas, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, parenteral nutrition and oncology.
In the past, Claris has grown at a strong pace with net sales increasing at a CAGR of 26.9% and net profit posting a strong CAGR of 65.6% over CY2005-09.
